• Largest national medical benefit manager in the U.S. expands coverage for FDA-approved Shield blood test for colorectal cancer (CRC) screening to eligible policyholders
  • Increasing total covered Shield lives ages 45 and older to approximately 90 million, representing the vast majority of eligible patients in the U.S.